Pathology AI for Precision Medicine

Intelligence for the Decisions that Matter Most

Pathology's AI platform¹ for the experts answering medicine's biggest questions, from discovery through diagnosis.

Clinical LAB SOLUTIONS

At the point of review

An immersive, operationally intelligent review experience for pathology's experts.

CLINICAL

Life Sciences SOLUTIONS

From tissue to treatment

Turn tissue into biomarker insights, move therapies through development and get them to the patients who need them.

LIFE SCIENCES

Trusted by 16 of the top 20 pharma companies and over 4,000 hospitals and clinics globally.

CONCENTRIQ

Pathology AI for
Precision Medicine

The Concentriq¹ portfolio powers precision medicine from discovery through diagnosis, with purpose-built solutions for biomarker research, clinical trials, companion diagnostics, and case review.

EXPLORE CONCENTRIQ

Best in KLAS 2026

Concentriq is the highest-rated digital pathology platform in both the United States and Europe. Find out why we’re rated #1 by customers.

READ THE KLAS REPORT

Trusted at scale. Proven in practice.

12M

cases managed annually by Proscia's customers

4,000+

hospitals and clinics served worldwide

16 of 20

top pharmaceutical companies run on Concentriq

30,000+

studies powered by Concentriq, from discovery to trials

100%

of customers told KLAS they would buy Concentriq again

FEATS OF STRENGTH VIDEO SERIES

The hardest part of going digital isn't the technology.

Behind every successful digital pathology deployment is a pathologist or lab leader who broke down barriers and moved their organization to Pathology AI. Feats of Strength tells their stories.

SEE THEIR STORIES

"The only way to evolve, to make our discipline evolve, is go for more."

Dr. Luis Cano

Clinical AI & Digital Pathology Consultant

"Understanding the needs from all of those groups of people, their various perspectives, packaging them into a justification that made sense for everybody and showed value to the entire organization, those were some of the most critical steps that we undertook."

Dr. Cherub Kim

Director, Medical Affairs and Clinical Informatics Lead

“Just go ahead and start. It’ll give you something to grow on.”

Dr. Amanda Hemmerich

Global Director of Digital Pathology Innovation
IQVIA Laboratories

"I think the defining moment for me was when I saw that first scanner and saw what it could do. It was like, okay, someday, this is the way we're gonna work.”

Dr. Derrick Forchetti

Pathologist
South Bend Medical Foundation

Latest Resources

Blog

We Didn't Start with the Tech: Building the Fifth Generation of Concentriq Alongside Pathologists

When we set out to build the Fifth Generation of Concentriq, we didn't start by asking what AI could do. We asked pathologists and lab directors a different question: what's slowing you down? The answer wasn't slide review, it was everything around it: manual steps, friction, and extra clicks. We focused on removing those barriers, so pathologists can spend their time on pathology instead of on the steps around it.

Press Release

Proscia Receives New FDA 510(k) Clearance for Concentriq AP-Dx with Predetermined Change Control Plan

Proscia® has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Concentriq® AP-Dx. The clearance includes compatibility with the Leica Aperio® GT 450 DX slide scanner, cloud deployment, and a Predetermined Change Control Plan (PCCP). Concentriq AP-Dx is a digital pathology platform for primary diagnosis used by laboratories of all sizes.

Webinar

Meet the Next Generation of Concentriq: Pathology’s AI Platform for Precision Medicine

Diagnostic labs and drug development programs are under more pressure than ever — and a pathology platform with AI bolted on can't keep up. See the first official demo of Concentriq Fifth Generation, built with an enterprise AI layer at its core. Hear directly from customers optimizing clinical diagnostic workflows and advancing drug development research.

Save my spot

View all

¹ The Concentriq portfolio includes distinct configurations. Concentriq AP-Dx is cleared for primary clinical diagnosis. Concentriq AP and Concentriq LS are for Research Use Only; not for use in diagnostic procedures. Proscia’s interoperable AI applications and native AI features are available for research use only on Concentriq AP. In some geographies, certain AI applications may be interoperable with Concentriq AP-Dx. Contact the AI application manufacturers for regulatory authorization status and indications for use. Proscia’s native AI features in Concentriq AP-Dx do not meet the definition of Artificial Intelligence as defined by Regulation (EU) 2024/1689.